Pfizer Inc. is a global, research-based biopharmaceutical company developing and
commercializing medicines and vaccines across therapeutic areas including oncology,
immunology, cardiovascular/metabolic disease, rare diseases and infectious diseases.
Cash generation and dividend capacity are influenced by product lifecycle dynamics,
patent expiries, pipeline execution, pricing and reimbursement conditions and the
pace of business development activity. Market performance is often driven by
clinical trial catalysts, regulatory milestones and medium-term expectations for
revenue diversification beyond mature franchises.